Browsing by Author "Casale T.B."

Now showing 1 - 7 of 7
  • No Thumbnail Available
    Item
    Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper
    (Blackwell Publishing Ltd, 2010) Bousquet J.; Schünemann H.J.; Zuberbier T.; Bachert C.; Baena-Cagnani C.E.; Bousquet P.J.; Brozek J.; Canonica G.W.; Casale T.B.; Demoly P.; Gerth Van Wijk R.; Ohta K.; Bateman E.D.; Calderon M.; Cruz A.A.; Dolen W.K.; Haughney J.; Lockey R.F.; Lötvall J.; O'byrne P.; Spranger O.; Togias A.; Bonini S.; Boulet L.P.; Camargos P.; Carlsen K.H.; Chavannes N.H.; Delgado L.; Durham S.R.; Fokkens W.J.; Fonseca J.; Haahtela T.; Kalayci O.; Kowalski M.L.; Larenas-Linnemann D.; Li J.; Mohammad Y.; Mullol J.; Naclerio R.; O'hehir R.E.; Papadopoulos N.; Passalacqua G.; Rabe K.F.; Pawankar R.; Ryan D.; Samolinski B.; Simons F.E.R.; Valovirta E.; Yorgancioglu A.; Yusuf O.M.; Agache I.; Aït-Khaled N.; Annesi-Maesano I.; Beghe B.; Ben Kheder A.; Blaiss M.S.; Boakye D.A.; Bouchard J.; Burney P.G.; Busse W.W.; Chan-Yeung M.; Chen Y.; Chuchalin A.G.; Costa D.J.; Custovic A.; Dahl R.; Denburg J.; Douagui H.; Emuzyte R.; Grouse L.; Humbert M.; Jackson C.; Johnston S.L.; Kaliner M.A.; Keith P.K.; Kim Y.Y.; Klossek J.M.; Kuna P.; Le L.T.; Lemiere C.; Lipworth B.; Mahboub B.; Malo J.L.; Marshall G.D.; Mavale-Manuel S.; Meltzer E.O.; Morais-Almeida M.; Motala C.; Naspitz C.; Nekam K.; Niggemann B.; Nizankowska-Mogilnicka E.; Okamoto Y.; Orru M.P.; Ouedraogo S.; Palkonen S.; Popov T.A.; Price D.; Rosado-Pinto J.; Scadding G.K.; Sooronbaev T.M.; Stoloff S.W.; Toskala E.; Van Cauwenberge P.; Vandenplas O.; Van Weel C.; Viegi G.; Virchow J.C.; Wang D.Y.; Wickman M.; Williams D.; Yawn B.P.; Zar H.J.; Zernotti M.; Zhong N.
    The links between asthma and rhinitis are well characterized. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines stress the importance of these links and provide guidance for their prevention and treatment. Despite effective treatments being available, too few patients receive appropriate medical care for both diseases. Most patients with rhinitis and asthma consult primary care physicians and therefore these physicians are encouraged to understand and use ARIA guidelines. Patients should also be informed about these guidelines to raise their awareness of optimal care and increase control of the two related diseases. To apply these guidelines, clinicians and patients need to understand how and why the recommendations were made. The goal of the ARIA guidelines is to provide recommendations about the best management options for most patients in most situations. These recommendations should be based on the best available evidence. Making recommendations requires the assessment of the quality of available evidence, deciding on the balance between benefits and downsides, consideration of patients' values and preferences, and, if applicable, resource implications. Guidelines must be updated as new management options become available or important new evidence emerges. Transparent reporting of guidelines facilitates understanding and acceptance, but implementation strategies need to be improved. © 2010 John Wiley & Sons A/S.
  • No Thumbnail Available
    Item
    Severe chronic allergic (and related) diseases: A uniform approach - A MeDALL - GA2 LEN - ARIA position paper
    (2012) Bousquet J.; Anto J.M.; Demoly P.; Schünemann H.J.; Togias A.; Akdis M.; Auffray C.; Bachert C.; Bieber T.; Bousquet P.J.; Carlsen K.H.; Casale T.B.; Cruz A.A.; Keil T.; Lodrup Carlsen K.C.; Maurer M.; Ohta K.; Papadopoulos N.G.; Roman Rodriguez M.; Samolinski B.; Agache I.; Andrianarisoa A.; Ang C.S.; Annesi-Maesano I.; Ballester F.; Baena-Cagnani C.E.; Basagaña X.; Bateman E.D.; Bel E.H.; Bedbrook A.; Beghé B.; Beji M.; Ben Kheder A.; Benet M.; Bennoor K.S.; Bergmann K.C.; Berrissoul F.; Bindslev Jensen C.; Bleecker E.R.; Bonini S.; Boner A.L.; Boulet L.P.; Brightling C.E.; Brozek J.L.; Bush A.; Busse W.W.; Camargos P.A.M.; Canonica G.W.; Carr W.; Cesario A.; Chen Y.Z.; Chiriac A.M.; Costa D.J.; Cox L.; Custovic A.; Dahl R.; Darsow U.; Didi T.; Dolen W.K.; Douagui H.; Dubakiene R.; El-Meziane A.; Fonseca J.A.; Fokkens W.J.; Fthenou E.; Gamkrelidze A.; Garcia-Aymerich J.; Van Wijk R.G.; Gimeno-Santos E.; Guerra S.; Haahtela T.; Haddad H.; Hellings P.W.; Hellquist-Dahl B.; Hohmann C.; Howarth P.; Hourihane J.O.; Humbert M.; Jacquemin B.; Just J.; Kalayci O.; Kaliner M.A.; Kauffmann F.; Kerkhof M.; Khayat G.; Koffi N'Goran B.; Kogevinas M.; Koppelman G.H.; Kowalski M.L.; Kull I.; Kuna P.; Larenas D.; Lavi I.; Le L.T.; Lieberman P.; Lipworth B.; Mahboub B.; Makela M.J.; Martin F.; Martinez F.D.; Marshall G.D.; Mazon A.; Melen E.; Meltzer E.O.; Mihaltan F.; Mohammad Y.; Mohammadi A.; Momas I.; Morais-Almeida M.; Mullol J.; Muraro A.; Naclerio R.; Nafti S.; Namazova-Baranova L.; Nawijn M.C.; Nyembue T.D.; Oddie S.; O'Hehir R.E.; Okamoto Y.; Orru M.P.; Ozdemir C.; Ouedraogo G.S.; Palkonen S.; Panzner P.; Passalacqua G.; Pawankar R.; Pigearias B.; Pin I.; Pinart M.; Pison C.; Popov T.A.; Porta D.; Postma D.S.; Price D.; Rabe K.F.; Ratomaharo J.; Reitamo S.; Rezagui D.; Ring J.; Roberts R.; Roca J.; Rogala B.; Romano A.; Rosado-Pinto J.; Ryan D.; Sanchez-Borges M.; Scadding G.K.; Sheikh A.; Simons F.E.R.; Siroux V.; Schmid-Grendelmeier P.D.; Smit H.A.; Sooronbaev T.; Stein R.T.; Sterk P.J.; Sunyer J.; Terreehorst I.; Toskala E.; Tremblay Y.; Valenta R.; Valeyre D.; Vandenplas O.; Van Weel C.; Vassilaki M.; Varraso R.; Viegi G.; Wang D.Y.; Wickman M.; Williams D.; Wöhrl S.; Wright J.; Yorgancioglu A.; Yusuf O.M.; Zar H.J.; Zernotti M.E.; Zidarn M.; Zhong N.; Zuberbier T.
    Concepts of disease severity, activity, control and responsiveness to treatment are linked but different. Severity refers to the loss of function of the organs induced by the disease process or to the occurrence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases (rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in order to have a uniform definition of severity, control and risk, usable in most situations. It is based on the appropriate diagnosis, availability and accessibility of treatments, treatment responsiveness and associated factors such as comorbidities and risk factors. This uniform definition will allow a better definition of the phenotypes of severe allergic (and related) diseases for clinical practice, research (including epidemiology), public health purposes, education and the discovery of novel therapies. Copyright © 2012 S. Karger AG, Basel.
  • No Thumbnail Available
    Item
    Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
    (2012) Bousquet J.; Schünemann H.J.; Samolinski B.; Demoly P.; Baena-Cagnani C.E.; Bachert C.; Bonini S.; Boulet L.P.; Bousquet P.J.; Brozek J.L.; Canonica G.W.; Casale T.B.; Cruz A.A.; Fokkens W.J.; Fonseca J.A.; Van Wijk R.G.; Grouse L.; Haahtela T.; Khaltaev N.; Kuna P.; Lockey R.F.; Lodrup Carlsen K.C.; Mullol J.; Naclerio R.; O'hehir R.E.; Ohta K.; Palkonen S.; Papadopoulos N.G.; Passalacqua G.; Pawankar R.; Price D.; Ryan D.; Simons F.E.R.; Togias A.; Williams D.; Yorgancioglu A.; Yusuf O.M.; Aberer W.; Adachi M.; Agache I.; Aït-Khaled N.; Akdis C.A.; Andrianarisoa A.; Annesi-Maesano I.; Ansotegui I.J.; Baiardini I.; Bateman E.D.; Bedbrook A.; Beghé B.; Beji M.; Bel E.H.; Ben Kheder A.; Bennoor K.S.; Bergmann K.C.; Berrissoul F.; Bieber T.; Bindslev Jensen C.; Blaiss M.S.; Boner A.L.; Bouchard J.; Braido F.; Brightling C.E.; Bush A.; Caballero F.; Calderon M.A.; Calvo M.A.; Camargos P.A.M.; Caraballo L.R.; Carlsen K.H.; Carr W.; Cepeda A.M.; Cesario A.; Chavannes N.H.; Chen Y.Z.; Chiriac A.M.; Chivato Pérez T.; Chkhartishvili E.; Ciprandi G.; Costa D.J.; Cox L.; Custovic A.; Dahl R.; Darsow U.; De Blay F.; Deleanu D.; Denburg J.A.; Devillier P.; Didi T.; Dokic D.; Dolen W.K.; Douagui H.; Dubakiene R.; Durham S.R.; Dykewicz M.S.; El-Gamal Y.; El-Meziane A.; Emuzyte R.; Fiocchi A.; Fletcher M.; Fukuda T.; Gamkrelidze A.; Gereda J.E.; González Diaz S.; Gotua M.; Guzmán M.A.; Hellings P.W.; Hellquist-Dahl B.; Horak F.; Hourihane J.O'B.; Howarth P.; Humbert M.; Ivancevich J.C.; Jackson C.; Just J.; Kalayci O.; Kaliner M.A.; Kalyoncu A.F.; Keil T.; Keith P.K.; Khayat G.; Kim Y.Y.; Koffi N'Goran B.; Koppelman G.H.; Kowalski M.L.; Kull I.; Kvedariene V.; Larenas-Linnemann D.; Le L.T.; Lemière C.; Li J.; Lieberman P.; Lipworth B.; Mahboub B.; Makela M.J.; Martin F.; Marshall G.D.; Martinez F.D.; Masjedi M.R.; Maurer M.; Mavale-Manuel S.; Mazon A.; Melen E.; Meltzer E.O.; Mendez N.H.; Merk H.; Mihaltan F.; Mohammad Y.; Morais-Almeida M.; Muraro A.; Nafti S.; Namazova-Baranova L.; Nekam K.; Neou A.; Niggemann B.; Nizankowska-Mogilnicka E.; Nyembue T.D.; Okamoto Y.; Okubo K.; Orru M.P.; Ouedraogo S.; Ozdemir C.; Panzner P.; Pali-Schöll I.; Park H.S.; Pigearias B.; Pohl W.; Popov T.A.; Postma D.S.; Potter P.; Rabe K.F.; Ratomaharo J.; Reitamo S.; Ring J.; Roberts R.; Rogala B.; Romano A.; Roman Rodriguez M.; Rosado-Pinto J.; Rosenwasser L.; Rottem M.; Sanchez-Borges M.; Scadding G.K.; Schmid-Grendelmeier P.; Sheikh A.; Sisul J.C.; Solé D.; Sooronbaev T.; Spicak V.; Spranger O.; Stein R.T.; Stoloff S.W.; Sunyer J.; Szczeklik A.; Todo-Bom A.; Toskala E.; Tremblay Y.; Valenta R.; Valero A.L.; Valeyre D.; Valiulis A.; Valovirta E.; Van Cauwenberge P.; Vandenplas O.; Van Weel C.; Vichyanond P.; Viegi G.; Wang D.Y.; Wickman M.; Wöhrl S.; Wright J.; Yawn B.P.; Yiallouros P.K.; Zar H.J.; Zernotti M.E.; Zhong N.; Zidarn M.; Zuberbier T.; Ang C.S.; Baigenzhin A.K.; Boakye D.A.; Briggs A.H.; Burney P.G.; Busse W.W.; Chuchalin A.G.; Haddad H.; Johnston S.L.; Kogevinas M.; Levy M.L.; Mohammadi A.; Oddie S.; Rezagui D.; Terreehorst I.; Warner J.O.
    Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified AR as mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, and other health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. ARIA is disseminated and implemented in more than 50 countries of the world. Ten years after the publication of the ARIA World Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children. © 2012 American Academy of Allergy, Asthma & Immunology.
  • No Thumbnail Available
    Item
    ARIA (Allergic rhinitis and its impact on asthma) Achievements in 10 years and future needs; [ARIA (Allerjik rinit ve astım üzerine etkisi) 10 yıldaki kazanımlar ve gelecekteki gereksinimler]
    (Ankara University, 2012) Yorganciog̀lu A.; Özdemir C.; Kalayci O.; Kalyoncu A.F.; Bachert C.; Baena-Cagnani C.E.; Casale T.B.; Chen Y.Z.; Cruz A.A.; Demoly P.; Fokkens W.J.; Lodrup Carlsen K.C.; Mohammad Y.; Mullol J.; Ohta K.; Papadopoulos N.G.; Pawankar R.; Samolinski B.; Schünemann H.J.; Yusuf O.M.; Zuberbier T.; Bousquet J.
    Allergic rhinitis and asthma represent global health problems for all age groups. Asthma and rhinitis frequently co-exist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization (WHO) workshop in 1999 and was published in 2001. ARIA has reclassified allergic rhinitis as mild/moderate-severe and intermittent/persistent. This classification schema closely reflects the impact of allergic rhinitis on patients. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of allergic rhinitis and asthma co-morbidities based on GRADE (Grading of Recommendation, Assessment, Development and Evaluation). ARIA has been disseminated and implemented in over 50 countries of the world. In Turkey, it is important to make a record of ARIA achievements and to identify the still unmet clinical, research and implementation needs in order to strengthen the 2011 EU Priority on allergy and asthma in children.
  • No Thumbnail Available
    Item
    MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
    (Mosby Inc., 2016) Bousquet J.; Schünemann H.J.; Hellings P.W.; Arnavielhe S.; Bachert C.; Bedbrook A.; Bergmann K.-C.; Bosnic-Anticevich S.; Brozek J.; Calderon M.; Canonica G.W.; Casale T.B.; Chavannes N.H.; Cox L.; Chrystyn H.; Cruz A.A.; Dahl R.; De Carlo G.; Demoly P.; Devillier P.; Dray G.; Fletcher M.; Fokkens W.J.; Fonseca J.; Gonzalez-Diaz S.N.; Grouse L.; Keil T.; Kuna P.; Larenas-Linnemann D.; Lodrup Carlsen K.C.; Meltzer E.O.; Mullol J.; Muraro A.; Naclerio R.N.; Palkonen S.; Papadopoulos N.G.; Passalacqua G.; Price D.; Ryan D.; Samolinski B.; Scadding G.K.; Sheikh A.; Spertini F.; Valiulis A.; Valovirta E.; Walker S.; Wickman M.; Yorgancioglu A.; Haahtela T.; Zuberbier T.; Aberer W.; Adachi M.; Agache I.; Akdis C.; Akdis M.; Annesi-Maesano I.; Ansotegui I.J.; Anto J.M.; Arshad S.H.; Baiardini I.; Baigenzhin A.K.; Barbara C.; Bateman E.D.; Beghé B.; Bel E.H.; Ben Kheder A.; Bennoor K.S.; Benson M.; Bernstein D.; Michael B.; Thomas B.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Boner A.; Bonini M.; Bonini S.; Bosse I.; Bouchard J.; Boulet L.-P.; Bourret R.A.; Bousquet P.J.; Braido F.; Briggs A.H.; Brightling C.E.; Buhl R.; Burney P.; Bush A.; Caballero-Fonseca F.; Caimmi D.P.; Camargos P.; Camuzat T.; Carlsen K.-H.; Carr W.; Sarabia A.C.; Chatzi L.; Chen Y.; Chiron R.; Chkhartishvili E.; Chuchalin A.; Ciprandi G.; Cirule I.; Correia de Sousa J.; Costa D.; Crooks G.; Custovic A.; Dahlen S.-E.; Darsow U.; De Blay F.; De Manuel Keenoy E.; Dedeu T.; Deleanu D.; Denburg J.; Didier A.; Dinh-Xuan A.-T.; Dokic D.; Douagui H.B.; Dubakiene R.; Durham S.; Dykewicz M.; El-Gamal Y.; Emuzyte R.; Fink-Wagner A.; Fiocchi A.; Forastiere F.; Gamkrelidze A.; Gemicioğlu B.; Gereda J.E.; Gerth van Wijk R.; Gotua M.; Grisle I.; Guzmán M.A.; Heinrich J.; Hellquist-Dahl B.; Horak F.; Howarth P.H.; Humbert M.; Hyland M.; Ivancevich J.-C.; Jares E.J.; Johnston S.L.; Jonquet O.; Joos G.; Jung K.-S.; Just J.; Jutel M.; Kaidashev I.P.; Khaitov M.; Kalayci O.; Kalyoncu F.; Keith P.; Khaltaev N.; Kleine-Tebbe J.; Klimek L.; N'Goran B.K.; Kolek V.; Koppelman G.H.; Kowalski M.; Kull I.; Kvedariene V.; Lambrecht B.; Lau S.; Laune D.; Le Thi Tuyet L.; Li J.; Lieberman P.; Lipworth B.J.; Renaud L.; Magard Y.; Magnan A.; Mahboub B.; Majer I.; Makela M.; Manning P.J.; Masjedi M.R.; Maurer M.; Mavale-Manuel S.; Melén E.; Melo-Gomes E.; Mercier J.; Merk H.; Miculinic N.; Mihaltan F.; Milenkovic B.; Mohammad Y.; Molimard M.; Momas I.; Montilla-Santana A.; Morais-Almeida M.; Mösges R.; Nadif R.; Namazova-Baranova L.; Neffen H.; Nekam K.; Neou A.; Niggemann B.; Nyembue D.; O'Hehir R.; Ohta K.; Okamoto Y.; Okubo K.; Ouedraogo S.; Paggiaro P.-L.; Pali-Schöll I.; Palmer S.; Panzner P.; Papi A.; Park H.-S.; Pavord I.; Pawankar R.; Pfaar O.; Picard R.; Pigearias B.; Pin I.; Plavec D.; Pohl W.; Popov T.; Postma D.S.; Potter P.; Poulsen L.K.; Rabe K.F.; Raciborski F.; Pontal F.R.; Reitamo S.; Repka-Ramirez M.-S.; Robalo-Cordeiro C.; Roberts G.; Rodenas F.; Rolland C.; Rodriguez M.R.; Romano A.; Rosado-Pinto J.; Rosario N.A.; Rosenwasser L.; Rottem M.; Sanchez-Borges M.; Sastre-Dominguez J.; Schmid-Grendelmeier P.; Serrano E.; Simons F.E.R.; Sisul J.-C.; Skrindo I.; Smit H.A.; Solé D.; Sooronbaev T.; Spranger O.; Stelmach R.; Strandberg T.; Sunyer J.; Thijs C.; Todo-Bom A.-M.; Triggiani M.; Valenta R.; Valero A.L.; van Hage M.; Vandenplas O.; Vezzani G.; Vichyanond P.; Viegi G.; Wagenmann M.; Wahn U.; De Yun W.; Williams D.; Wright J.; Yawn B.P.; Yiallouros P.; Yusuf O.M.; Zar H.J.; Zernotti M.; Zhang L.; Zhong N.; Zidarn M.
    The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials. © 2016 The Authors
  • No Thumbnail Available
    Item
    AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation
    (European Respiratory Society, 2016) Bousquet J.; Barbara C.; Bateman E.; Bel E.; Bewick M.; Chavannes N.H.; Cruz A.A.; Haahtela T.; Hellings P.W.; Khaltaev N.; Carlsen K.L.; Muraro A.; Cordeiro C.R.; Rosado-Pinto J.; Samolinski B.; Strandberg T.; Valiulis A.; Yorgancioglu A.; Zuberbier T.; Adcock I.; Addis A.; Agache I.; Agusti A.; Alonso A.; Annesi Maesano I.; Anto J.M.; Bachert C.; Baena-Cagnani C.; Bai C.; Baigenzhin A.; Barnes P.J.; Beck L.; Bedbrook A.; Benezet O.; Bennoor K.S.; Benson M.; Bernabeu-Wittel M.; Bindslev Jensen C.; Blain H.; Blasi F.; Bonini M.; Bonini S.; Boulet L.P.; Bourdin A.; Bourret R.; Bousquet P.J.; Brightling C.E.; Briggs A.; Brozek J.; Buhl R.; Bush A.; Caimmi D.; Calderon M.; Calverley P.; Camargos P.; Camuzat T.; Canonica G.W.; Carlsen K.H.; Casale T.B.; Cazzola M.; Cepeda Sarabia A.M.; Cesario A.; Chen Y.Z.; Chkhartishvili E.; Chiron R.; Chuchalin A.; Chung K.F.; Cox L.; Crooks G.; Crooks M.G.; Custovic A.; Dahl R.; Dahlen S.E.; De Blay F.; Dedeu T.; Deleanu D.; Demoly P.; Devillier P.; Didier A.; Dinh Xuan A.T.; Djukanovic R.; Dokic D.; Douagui H.; Dubakiene R.; Eglin S.; Elliot F.; Emuzyte R.; Fabbri L.; Fink-Wagner A.; Fletcher M.; Fokkens W.J.; Fonseca J.; Franco A.; Frith P.; Furber A.; Gaga M.; Gamkrelidze A.; Garcia Aymerich J.; González-Díaz S.; Gouzi F.; Garcés J.; Guzmán M.A.; Harrison D.; Hayot M.; Heaney L.; Heinrich J.; Hooper J.; Humbert M.; Hyland M.; Iaccarino G.; Jakovenko D.; Jardim J.; Jeandel C.; Jenkins C.; Johnston S.L.; Jonquet O.; Joos G.; Jung K.S.; Kalayci O.; Karunanithi S.; Keil T.; Kolek V.; Kowalski M.; Kull I.; Kuna P.; Kvedariene V.; Le L.T.; Louis R.; MacNee W.; Mair A.; Manning P.; Manuel Keenoy M.E.; Majer I.; Masjedi M.R.; Melén E.; Melo Gomes E.; Menzies-Gow A.; Mercier G.; Mercier J.; Michel J.P.; Miculinic N.; Mihaltan F.; Milenkovic B.; Molimard M.; Momas I.; Montilla-Santana A.; Morais Almeida M.; Morgan M.; N'Diaye M.; Nafti S.; Nekam; Neou A.; Nicod L.; O'Hehir R.; Ohta K.; Paggiaro P.; Palkonen S.; Palmer S.; Papadopoulos N.G.; Papi A.; Passalacqua G.; Pavord I.; Pedersen S.; Pigearias B.; Plavec D.; Postma D.S.; Price D.; Rabe K.F.; Radier Pontal F.; Redon J.; Rennard S.; Roberts J.; Robine J.M.; Roca J.; Roche N.; Rodenas F.; Roggeri A.; Rolland C.; Ryan D.; Sanchez-Borges M.; Schünemann H.J.; Sheikh A.; Shields M.; Siafakas N.; Sibille Y.; Similowski T.; Small I.; Sola-Morales O.; Sooronbaev T.; Stelmach R.; Sterk P.J.; Stiris T.; Sud P.; Tellier V.; To T.; Todo Bom A.; Triggiani M.; Valenta R.; Valero A.L.; Valovirta E.; Vandenplas O.; Van Ganse E.; Vasankari T.; Vestbo J.; Vezzani G.; Viegi G.; Visier L.; Vogelmeier C.; Vontetsianos T.; Wagstaff R.; Wallaert B.; Wahn U.; Whalley B.; Wickman M.; Williams D.; Wilson N.; Yawn B.P.; Yiallouros P.; Yusuf O.; Zar H.J.; Zhong N.; Zidarn M.
    [No abstract available]
  • No Thumbnail Available
    Item
    ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) 
POLLAR (Impact of Air POLLution on Asthma and Rhinitis)
GARD Demonstration project
    (Blackwell Publishing Ltd, 2019) Bosnic-Anticevich S.; Costa E.; Menditto E.; Lourenço O.; Novellino E.; Bialek S.; Briedis V.; Buonaiuto R.; Chrystyn H.; Cvetkovski B.; Di Capua S.; Kritikos V.; Mair A.; Orlando V.; Paulino E.; Salimäki J.; Söderlund R.; Tan R.; Williams D.M.; Wroczynski P.; Agache I.; Ansotegui I.J.; Anto J.M.; Bedbrook A.; Bachert C.; Bewick M.; Bindslev-Jensen C.; Brozek J.L.; Canonica G.W.; Cardona V.; Carr W.; Casale T.B.; Chavannes N.H.; Correia de Sousa J.; Cruz A.A.; Czarlewski W.; De Carlo G.; Demoly P.; Devillier P.; Dykewicz M.S.; Gaga M.; El-Gamal Y.; Fonseca J.; Fokkens W.J.; Guzmán M.A.; Haahtela T.; Hellings P.W.; Illario M.; Ivancevich J.C.; Just J.; Kaidashev I.; Khaitov M.; Khaltaev N.; Keil T.; Klimek L.; Kowalski M.L.; Kuna P.; Kvedariene V.; Larenas-Linnemann D.E.; Laune D.; Le L.T.T.; Lodrup Carlsen K.C.; Mahboub B.; Maier D.; Malva J.; Manning P.J.; Morais-Almeida M.; Mösges R.; Mullol J.; Münter L.; Murray R.; Naclerio R.; Namazova-Baranova L.; Nekam K.; Nyembue T.D.; Okubo K.; O'Hehir R.E.; Ohta K.; Okamoto Y.; Onorato G.L.; Palkonen S.; Panzner P.; Papadopoulos N.G.; Park H.-S.; Pawankar R.; Pfaar O.; Phillips J.; Plavec D.; Popov T.A.; Potter P.C.; Prokopakis E.P.; Roller-Wirnsberger R.E.; Rottem M.; Ryan D.; Samolinski B.; Sanchez-Borges M.; Schunemann H.J.; Sheikh A.; Sisul J.C.; Somekh D.; Stellato C.; To T.; Todo-Bom A.M.; Tomazic P.V.; Toppila-Salmi S.; Valero A.; Valiulis A.; Valovirta E.; Ventura M.T.; Wagenmann M.; Wallace D.; Waserman S.; Wickman M.; Yiallouros P.K.; Yorgancioglu A.; Yusuf O.M.; Zar H.J.; Zernotti M.E.; Zhang L.; Zidarn M.; Zuberbier T.; Bousquet J.
    Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care. © 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.